ANCA-positive vasculitis

Flash FDA approval sends ChemoCentryx spiralling upwards
Pharmaforum
Sun, 10/10/21 - 09:48 pm
ChemoCentryx
FDA
avacopan
Tavneos
ANCA-positive vasculitis
Adcomm splits slightly in favor of FDA approving ChemoCentryx’s rare disease drug
Endpoints
Thu, 05/6/21 - 11:06 pm
FDA
advisory panels
ChemoCentryx
avacopan
ANCA-positive vasculitis
ChemoCentryx Drug Hits Co-Primary Endpoints in Phase III Vasculitis Trial
BioSpace
Tue, 11/26/19 - 11:37 pm
ChemoCentryx
Vifor Fresenius Medical Care Renal Pharma
avacopan
ANCA-positive vasculitis
clinical trials
GlaxoSmithKline Launches Phase 3 Trial for Benlysta
Motley Fool
Fri, 04/5/13 - 10:19 am
GSK
Benlysta
ANCA-positive vasculitis